Actionable spontaneous antibody responses antagonize malignant progression in ovarian carcinoma.

Handley KF, Mehta S, Martin AL, Biswas S, Maharaj K, Nagy MZ, Mine JA, Cortina C, Yu X, Sprenger K, Mandal G, Innamarato P, Powers JJ, Harro CM, Chaurio RA, Anadon CM, Shahzad MM, Flores I, Conejo-Garcia JR. Actionable spontaneous antibody responses antagonize malignant progression in ovarian carcinoma. Gynecol Oncol. 2023 06; 173:114-121.

View in: PubMed

subject areas

Adenocarcinoma, Clear Cell
Animals
Antibody Formation
Apoptosis
Carcinoma, Endometrioid
Cell Line, Tumor
Endometriosis
Female
Humans
Immunoglobulin A
Mice
Ovarian Neoplasms
Syntenins

authors with profiles

Idhaliz Flores

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support